| Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence … C Lapenta, SM Santini, M Logozzi, M Spada, M Andreotti, T Di Pucchio, ... The Journal of experimental medicine 198 (2), 361-367, 2003 | 167 | 2003 |
| IFN‐α‐conditioned dendritic cells are highly efficient in inducing cross‐priming CD8+ T cells against exogenous viral antigens C Lapenta, SM Santini, M Spada, S Donati, F Urbani, D Accapezzato, ... European journal of immunology 36 (8), 2046-2060, 2006 | 163 | 2006 |
| Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action R Di Santo, R Costi, A Roux, M Artico, A Lavecchia, L Marinelli, ... Journal of medicinal chemistry 49 (6), 1939-1945, 2006 | 122 | 2006 |
| Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume A Vigano, S Vella, M Saresella, A Vanzulli, D Bricalli, S Di Fabio, ... Aids 14 (3), 251-261, 2000 | 117 | 2000 |
| Monocyte-derived dendritic cells generated after a short-term culture with IFN-α and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus … L Santodonato, G D’Agostino, R Nisini, S Mariotti, DM Monque, M Spada, ... The Journal of Immunology 170 (10), 5195-5202, 2003 | 107 | 2003 |
| Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial … G d'Ettorre, G Rossi, C Scagnolari, M Andreotti, N Giustini, S Serafino, ... Immunity, inflammation and disease 5 (3), 244-260, 2017 | 102 | 2017 |
| IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS … L Gabriele, P Borghi, C Rozera, P Sestili, M Andreotti, A Guarini, ... Blood 103 (3), 980-987, 2004 | 102 | 2004 |
| HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS G d'Ettorre, M Paiardini, L Zaffiri, M Andreotti, G Ceccarelli, C Rizza, ... Current HIV research 9 (3), 148-153, 2011 | 92 | 2011 |
| Maternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after delivery M Giuliano, M Andreotti, G Liotta, H Jere, JB Sagno, M Maulidi, ... PLoS One 8 (7), e68950, 2013 | 81 | 2013 |
| Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement … M Giuliano, G Guidotti, M Andreotti, MF Pirillo, P Villani, G Liotta, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (3), 286-291, 2007 | 74 | 2007 |
| Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, ... Journal of Clinical Virology 46 (4), 367-370, 2009 | 73 | 2009 |
| Comparison of the Cepheid GeneXpert and Abbott M2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infection S Ceffa, R Luhanga, M Andreotti, D Brambilla, F Erba, H Jere, ... Journal of virological methods 229, 35-39, 2016 | 70 | 2016 |
| Correlation between HIV-1 viral load quantification in plasma, dried blood spots, and dried plasma spots using the Roche COBAS Taqman assay M Andreotti, M Pirillo, G Guidotti, S Ceffa, G Paturzo, P Germano, ... Journal of Clinical Virology 47 (1), 4-7, 2010 | 68 | 2010 |
| A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients … M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 20 (1), 11-19, 1999 | 66 | 1999 |
| Novel quinolinonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, and biological activities R Di Santo, R Costi, A Roux, G Miele, GC Crucitti, A Iacovo, F Rosi, ... Journal of medicinal chemistry 51 (15), 4744-4750, 2008 | 65 | 2008 |
| Residual viraemia in subjects with chronic HIV infection and viral load< 50 copies/ml: the impact of highly active antiretroviral therapy L Palmisano, M Giuliano, E Nicastri, MF Pirillo, M Andreotti, CM Galluzzo, ... Aids 19 (16), 1843-1847, 2005 | 61 | 2005 |
| Tuberculosis case finding with combined rapid point-of-care assays (Xpert MTB/RIF and Determine TB LAM) in HIV-positive individuals starting antiretroviral therapy in Mozambique M Floridia, F Ciccacci, M Andreotti, A Hassane, Z Sidumo, NA Magid, ... Clinical Infectious Diseases 65 (11), 1878-1883, 2017 | 55 | 2017 |
| Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical trial F Menichetti, P Popoli, M Puopolo, SS Alegiani, G Tiseo, A Bartoloni, ... JAMA network open 4 (11), e2136246-e2136246, 2021 | 54 | 2021 |
| Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety L Palombi, MF Pirillo, M Andreotti, G Liotta, F Erba, JB Sagno, M Maulidi, ... Antiviral therapy 17 (8), 1511-1519, 2012 | 54 | 2012 |
| Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed … L Palmisano, M Giuliano, R Bucciardini, V Fragola, M Andreotti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 46 (1), 39-47, 2007 | 47 | 2007 |
